Compare NVCR & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVCR | RQI |
|---|---|---|
| Founded | 2000 | 2002 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2015 | N/A |
| Metric | NVCR | RQI |
|---|---|---|
| Price | $12.00 | $12.43 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $28.08 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 450.0K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $7.72 | N/A |
| Revenue Next Year | $6.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $10.39 |
| 52 Week High | $20.49 | $13.39 |
| Indicator | NVCR | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 38.18 |
| Support Level | $10.86 | $12.14 |
| Resistance Level | $14.13 | $12.63 |
| Average True Range (ATR) | 1.00 | 0.20 |
| MACD | -0.06 | -0.13 |
| Stochastic Oscillator | 25.37 | 5.83 |
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.